Pancreatic Cancer Research

ResearcherCentre National de la Recherche ScientifiqueActive in the last 2 years

Shulin Zhao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8233-0115; OpenAlex author ID A5100664082. Sources: OpenAlex.

Their work

Papers
16 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
76
Papers, trials and grants by year

2019: 3 papers · 2020: 1 paper · 2021: 1 paper · 2022: 3 papers · 2023: 3 papers · 2024: 2 papers · 2025: none · 2026: 3 papers

Papers 16

  1. Prognostic and predictive values of transcriptomic signatures in metastatic pancreatic cancer: A biomarker analysis of three French multicenter prospective ran… Co-author DOI 10.1016/j.canlet.2026.218745↗
  2. Resident tissue macrophages transfer selenium transporter protein to protect pancreatic cancer from ferroptosis. Co-author DOI 10.1016/j.cell.2026.09.001↗
  3. Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-dose stereotactic body radiotherapy. Co-author DOI 10.1038/s41416-025-03274-0↗
  4. Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41591-023-02790-x↗
  5. Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after Total Neoadjuvant Therapy including Stereotactic Body Radiotherapy Co-author DOI 10.1101/2024.04.30.591890↗
  6. Risk factors for and prognostic values of postoperative acute kidney injury after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: A retrospective… Co-author DOI 10.1002/cam4.5543↗
  7. Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment. Co-author DOI 10.1038/s41467-023-40314-w↗
  8. Comprehensive machine learning-generated classifier identifies pro-metastatic characteristics and predicts individual treatment in pancreatic cancer: A multice… Co-author DOI 10.7150/thno.84978↗
  9. The impact of Omicron pandemic and COVID-19 vaccination on the pancreatic adenocarcinoma patients. Co-author DOI 10.1002/aac2.12056↗
  10. BRCA1 and RAD51C promotor methylation in human resectable pancreatic adenocarcinoma. First author DOI 10.1016/j.clinre.2022.101880↗
  11. Identification of EMT-related alternative splicing event of TMC7 to promote invasion and migration of pancreatic cancer. Co-author DOI 10.3389/fimmu.2022.1089008↗
  12. Prognostic Relevance of Pancreatic Adenocarcinoma Whole-Tumor Transcriptomic Subtypes and Components. Co-author DOI 10.1158/1078-0432.ccr-21-1907↗
  13. Plasma circulating tumor DNA in pancreatic adenocarcinoma for screening, diagnosis, prognosis, treatment and follow-up: A systematic review. Co-author DOI 10.1016/j.ctrv.2020.102028↗
  14. Perineural invasion is related to p38 mitogen-activated protein kinase pathway activation and promotes tumor growth and chemoresistance in pancreatic cancer. Co-author DOI 10.1002/jcb.28457↗
  15. Comparison of Radical Antegrade Modular Pancreatosplenectomy with Standard Retrograde Pancreatosplenectomy for Left-Sided Pancreatic Cancer: A Meta-Analysis an… Co-author DOI 10.12659/msm.914540↗
  16. TRIANGLE operation for borderline resectable pancreatic cancer in total pancreatectomy. Co-author DOI 10.21037/tcr.2019.09.50↗

Closest collaborators

The 25 strongest of 76 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Baiyong Shen · 8 shared papers, 2019–2026 · strength 1.21
  2. Xiaxing Deng · 8 shared papers, 2019–2024 · strength 1.15
  3. Jean‐Baptiste Bachet · 7 shared papers, 2020–2026 · strength 1.11
  4. Rémy Nicolle · 5 shared papers, 2021–2026 · strength 0.87
  5. Pierre Laurent‐Puig · 5 shared papers, 2020–2026 · strength 0.74
  6. Jerome F. Cros · 4 shared papers, 2021–2026 · strength 0.63
  7. Chenghong Peng · 4 shared papers, 2019–2023 · strength 0.52
  8. Louis de Mestier · 3 shared papers, 2021–2026 · strength 0.49
  9. Léo Mas · 3 shared papers, 2020–2026 · strength 0.49
  10. Raëf Abdallah · 3 shared papers, 2020–2026 · strength 0.48
  11. Julien Taı̈eb · 3 shared papers, 2020–2026 · strength 0.48
  12. Lingxi Jiang · 3 shared papers, 2023–2024 · strength 0.41
  13. Julie Navez · 2 shared papers, 2024–2026 · strength 0.38
  14. Pieter Demetter · 2 shared papers, 2024–2026 · strength 0.38
  15. Nicky D’Haene · 2 shared papers, 2024–2026 · strength 0.38
  16. Jean‐Luc Van Laethem · 2 shared papers, 2024–2026 · strength 0.38
  17. Christelle Bouchart · 2 shared papers, 2024–2026 · strength 0.38
  18. Matthieu Hein · 2 shared papers, 2024–2026 · strength 0.38
  19. Oier Azurmendi Senar · 2 shared papers, 2024–2026 · strength 0.38
  20. Kosta Stosic · 2 shared papers, 2024–2026 · strength 0.38
  21. Ilse Rooman · 2 shared papers, 2024–2026 · strength 0.38
  22. Tatjana Arsenijevic · 2 shared papers, 2024–2026 · strength 0.38
  23. Hao Qian · 3 shared papers, 2019–2022 · strength 0.38
  24. Yuanchi Weng · 3 shared papers, 2019–2022 · strength 0.38
  25. Shuyu Zhai · 3 shared papers, 2019–2023 · strength 0.33

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.